BILLS-117hr4369ih.pdf

22:44 Jul 19 4369 one year 2021 the 21st Century 21st 1 Century annual JULY 6, 2021 19 years 2022 through 2026 later than 60 days later than 2 years 1ST SESSION H. R. 4369 2 day 1965 annually

the ‘‘National Centers of

PO 00000 Frm 00004 PO 00000 Frm 00007 PO 00000 Frm 00008 Fmt PO 00000 Frm 00002 PO 00000 Frm 00005 PO 00000 Frm 00010 PO 00000 Frm 00009 PO 00000 Frm 00011 Fmt PO 00000 Frm 00003 Fmt PO 00000 Frm 00006 PO 00000 Frm 00001

the United States the United States of America

Congress National Centers of Excellence National Center of Excellence Excellence National Centers of Excellence a National Center of Excellence FDA Drug Administration Center of Excellence THE HOUSE OF REPRESENTATIVES U.S.C. the Food and Drug Food and Drug Administration Pharmaceutical Manufacturing a ‘National Center of Excellence’ the Food and Drug Administration the Department of Health the Food and Drug Ad- 1 Continuous Pharmaceutical Center for Excellence Continuous Pharmaceutical Manufacturing House of Representa- DESIGNATION.—A the Food and Drug Adminis- fed the Commissioner of Food and Drugs National Centers Continuous Pharmaceutical Manufacturing Centers SEC Health and Human Services the National Centers of Excellence Senate the Committee on Energy and Commerce

PALLONE GUTHRIE

continuous pharmaceutical manufacturing excellence pharmaceutical centers excellence manufacturing center excellence national center manufac turing turing cures manufacturers manufac higher education designation